Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc. (CRON) generates frequent news as a cannabinoid-focused company active in medical and adult-use cannabis markets across Canada, Israel and multiple international regions. Company updates often highlight brand performance, international expansion, product launches and financial results, offering investors and industry observers insight into how Cronos executes its global cannabis strategy.
News coverage for Cronos commonly includes quarterly earnings releases, where the company reports net revenue, gross profit, adjusted EBITDA and commentary on business performance by geography and brand. These releases also describe developments such as the consolidation and expansion of cultivation operations at Cronos Growing Company Inc. (Cronos GrowCo) and the company’s cash and short-term investment position.
Another major category of Cronos news involves brand and product announcements. Recent press releases describe new SOURZ by Spinach® Fully Blasted multipack gummies, seasonal Spinach® Caramel Green Apple gummies and vapes, and Lord Jones® Live Resin Fusions™ pre-rolls in Canada. These updates show how Cronos uses its Spinach® and Lord Jones® brands to introduce new formats and flavor profiles in the Canadian adult-use market.
Cronos also issues news on its international footprint and strategic transactions. Examples include the expansion of PEACE NATURALS® medical cannabis distribution in Switzerland through a partnership with Dascoli Pharma AG, and a definitive agreement for a Cronos subsidiary to acquire CanAdelaar B.V., a licensed producer in the Netherlands’ adult-use cannabis pilot program. In addition, the company has announced a junior secured convertible loan investment in High Tide Inc., a cannabis retailer, outlining the terms of that financing.
Investors and followers of CRON can use this news feed to review earnings announcements, track new product introductions under Spinach®, PEACE NATURALS® and Lord Jones®, and monitor strategic moves such as international partnerships, acquisitions and capital investments.
Cronos Group (NASDAQ: CRON) reported strong Q2 2025 results with net revenue increasing 21% year-over-year to $33.5 million. The company achieved its highest-ever international and Israel revenue, with PEACE NATURALS® maintaining its position as the top cannabis brand in Israel.
Key financial metrics include gross profit of $14.5 million (up 130% YoY), improved gross margin to 43%, and Adjusted EBITDA of $1.7 million. The company maintains a strong balance sheet with $834 million in cash and short-term investments.
Notable developments include Spinach® ranking as Canada's second most popular cannabis brand with 4.7% market share, completion of the Cronos GrowCo expansion, and a strategic C$25.2 million investment in High Tide Inc. The company also successfully resolved the Israeli anti-dumping duty issue and expanded PEACE NATURALS® into new international markets.
Cronos Group (NASDAQ: CRON) has scheduled its 2025 second quarter earnings conference call for Thursday, August 7, 2025 at 8:30 a.m. ET. The company's senior management will present financial results and conduct a Q&A session with the investment community.
Participants can register for the call and webcast through the company's investor relations website. To ensure timely participation, attendees are encouraged to dial in fifteen minutes before the scheduled start time. A replay of the webcast will be available on Cronos Group's website after the event.
High Tide Inc. (NASDAQ: HITI) has secured a $30 million convertible debt through a loan agreement with Cronos Group Inc. The junior secured loan bears a 4% annual interest rate and has a 5-year term. The debt is convertible into High Tide common shares at $4.20 per share.
As part of the deal, Cronos received a warrant exercisable into 3,836,317 common shares at $3.91 per share, representing a 25% premium to the 30-day VWAP. High Tide plans to use the capital for future acquisitions and organic growth, aiming to expand its Canadian store network beyond 300 locations. The company currently operates 202 Canna Cabana locations across Canada, making it the second-largest cannabis retailer globally by store count.
Cronos Group (NASDAQ: CRON) has announced its expansion into the Swiss medical cannabis market through a partnership with Dascoli Pharma AG. Under the agreement, Cronos will supply its PEACE NATURALS® branded cannabis flower products through Dascoli's established medical network in Switzerland.
The expansion includes five cannabis flower varieties: GMO Cookies, Space Cake, Atomic Sour Grapefruit, Sonic Lemon Fuel, and Wedding Cake. The PEACE NATURALS® brand is now available in seven international markets, including Australia, Canada, Germany, Israel, Malta, Switzerland, and the UK.
Cronos Group (NASDAQ: CRON) announced the results of its 2025 Annual Meeting of Shareholders, with a 71.87% shareholder participation representing 276,989,452 common shares. All nominated directors were successfully elected with over 92.3% approval rates. Notably, shareholders approved the executive compensation advisory resolution with 94.13% support and confirmed Davidson & Company LLP as the independent auditor for fiscal year 2025.
The board election saw strong support for all directors, with Dominik Meier receiving the highest approval at 96.94%, followed by Kamran Khan at 96.92%. Michael Gorenstein received 92.38% of votes in favor, representing the lowest but still overwhelmingly positive support among the directors.
Cronos Group (NASDAQ: CRON) (TSX: CRON) has announced its upcoming 2025 Annual Meeting of Shareholders, scheduled for Friday, June 20, 2025, at 11:00 a.m. ET. The meeting will be conducted in a virtual-only format through a live audio webcast.
Key Meeting Details:
- Shareholders and proxyholders can participate remotely regardless of location
- Participants will have opportunities to ask questions and vote
- Meeting access available at virtualshareholdermeeting.com/CRON2025
- Detailed instructions and formal business agenda available on Cronos investor relations website
A replay of the Annual Meeting will be accessible through the company's investor relations website approximately 24 hours after the event concludes. The virtual format ensures equal participation opportunities for all registered shareholders and appointed proxyholders.
Cronos Group (NASDAQ: CRON) (TSX: CRON) has scheduled its 2025 first quarter earnings conference call for Thursday, May 8, 2025, at 8:30 a.m. ET. The company's senior management will present financial results and take questions from the investment community following prepared remarks.
Interested participants can register for the conference call and webcast through the company's investor relations website at https://ir.thecronosgroup.com/events-presentations. To ensure timely access, participants are encouraged to dial in fifteen minutes before the scheduled start time. A replay of the webcast will be made available on Cronos' website after the event.
Cronos Group (NASDAQ: CRON) has announced the launch of new cannabis products under its Spinach® brand, introducing three new 1.2g vape products and expanding its SOURZ by Spinach® edible line.
The new vape lineup features:
- Mango Kiwi Haze CBC (Sativa) with 1:10 CBC-to-THC ratio
- Peach Passionfruit Kush CBN (Indica) with 1:10 CBN-to-THC ratio
- Strawberry Watermelon OG CBG (Hybrid) with 1:10 CBG-to-THC ratio
Each vape contains 1,000mg of THC and features winterized, distilled cannabis extract with ceramic heaters and stainless steel components. The SOURZ by Spinach® Fully Blasted lineup includes new 10mg THC gummies enhanced with rare cannabinoids in three flavors: Mango Lime (with CBC), Peach Passionfruit (with CBN), and Strawberry Watermelon (with CBG).